BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klieber S, Torreilles F, Guillou F, Fabre G. The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction. Methods Mol Biol 2010;640:295-308. [PMID: 20645059 DOI: 10.1007/978-1-60761-688-7_16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Xia L, Hong X, Sakban RB, Qu Y, Singh NH, Mcmillian M, Dallas S, Silva J, Sensenhauser C, Zhao S, Lim HK, Yu H. Cytochrome P450 induction response in tethered spheroids as a three-dimensional human hepatocyte in vitro model: CYP induction in tethered spheroids. J Appl Toxicol 2016;36:320-9. [DOI: 10.1002/jat.3189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
2 Vinardell M. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS). Regulatory Toxicology and Pharmacology 2015;71:198-204. [DOI: 10.1016/j.yrtph.2014.12.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
3 Wang Z, Luo X, Anene-Nzelu C, Yu Y, Hong X, Singh NH, Xia L, Liu S, Yu H. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening. J Appl Toxicol 2015;35:909-17. [PMID: 25512232 DOI: 10.1002/jat.3090] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
4 Cho YY, Jeong HU, Kim JH, Lee HS. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes. Drug Des Devel Ther 2014;8:2137-45. [PMID: 25395831 DOI: 10.2147/DDDT.S72305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Lafaille F, Solassol I, Enjalbal C, Bertrand B, Doulain P, Vappiani J, Bonnet P, Deleuze-masquéfa C, Bressolle FM. Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2014;88:429-40. [DOI: 10.1016/j.jpba.2013.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
6 Dudda A, Kuerzel GU. Metabolism Studies In Vitro and In Vivo. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays 2013. [DOI: 10.1007/978-3-642-25240-2_46] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Sahi J, Smith C, Easterwood L, Grepper S, Lecluyse E. Assessing the Hepatic Disposition and Toxicity of Xenobiotics Using Primary Hepatocytes. Encyclopedia of Drug Metabolism and Interactions 2012. [DOI: 10.1002/9780470921920.edm137] [Reference Citation Analysis]
8 Bierwolf J, Lutgehetmann M, Deichmann S, Erbes J, Volz T, Dandri M, Cohen S, Nashan B, Pollok J. Primary Human Hepatocytes from Metabolic-Disordered Children Recreate Highly Differentiated Liver-Tissue-Like Spheroids on Alginate Scaffolds. Tissue Engineering Part A 2012;18:1443-53. [DOI: 10.1089/ten.tea.2012.0029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
9 Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, Ellis E, Hovatta O. Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution. World J Hepatol 2012; 4(5): 176-183 [PMID: 22662286 DOI: 10.4254/wjh.v4.i5.176] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]